BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1486188)

  • 21. Endothelin receptor blockade in severe acute pancreatitis leads to systemic enhancement of microcirculation, stabilization of capillary permeability, and improved survival rates.
    Foitzik T; Eibl G; Hotz HG; Faulhaber J; Kirchengast M; Buhr HJ
    Surgery; 2000 Sep; 128(3):399-407. PubMed ID: 10965310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emodin and baicalein inhibit sodium taurocholate-induced vacuole formation in pancreatic acinar cells.
    Li J; Zhou R; Bie BB; Huang N; Guo Y; Chen HY; Shi MJ; Yang J; Zhang J; Li ZF
    World J Gastroenterol; 2018 Jan; 24(1):35-45. PubMed ID: 29358880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rosmarinic Acid Attenuates Sodium Taurocholate-Induced Acute Pancreatitis in Rats by Inhibiting Nuclear Factor-κB Activation.
    Fan YT; Yin GJ; Xiao WQ; Qiu L; Yu G; Hu YL; Xing M; Wu DQ; Cang XF; Wan R; Wang XP; Hu GY
    Am J Chin Med; 2015; 43(6):1117-35. PubMed ID: 26364660
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protective effect of nafamostat mesilate on cellular and lysosomal fragility of acinar cells in rat cerulein pancreatitis.
    Manabe T; Hirano T; Imanishi K; Ando K; Yotsumoto F; Tobe T
    Int J Pancreatol; 1992 Oct; 12(2):167-72. PubMed ID: 1281204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exogenous leptin protects rat models of sodium taurocholate‑induced severe acute pancreatitis through endocrinal and immunological pathways.
    Qi H; Lu Q; Yin C; Xiao H; Wen Y; Zhang S; Cui Q; Yang W
    Mol Med Rep; 2017 Nov; 16(5):6306-6312. PubMed ID: 28849043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of endothelin-1 receptor antagonists in acute experimental pancreatitis in the rats.
    Dlugosz JW; Nowak K; Laszewicz W; Andrzejewska A; Wroblewski E
    Exp Toxicol Pathol; 2003 Sep; 55(2-3):137-45. PubMed ID: 14620534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ghrelin attenuates the development of acute pancreatitis in rat.
    Dembinski A; Warzecha Z; Ceranowicz P; Tomaszewska R; Stachura J; Konturek SJ; Konturek PC
    J Physiol Pharmacol; 2003 Dec; 54(4):561-73. PubMed ID: 14726611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does antecedent ethanol intake affect course of taurocholate pancreatitis in rats?
    Dlugosz JW; Wroblewski E; Poplawski C; Gabryelewicz A; Andrzejewska A
    Dig Dis Sci; 1997 May; 42(5):944-52. PubMed ID: 9149046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective effects of a PAF receptor antagonist and a neutrophil elastase inhibitor on multiple organ failure induced by cerulein plus lipopolysaccharide in rats.
    Yamano M; Umeda M; Miyata K; Yamada T
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Aug; 358(2):253-63. PubMed ID: 9750012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Local administration of human pancreatic secretory trypsin inhibitor prevents the development of experimental acute pancreatitis in rats and dogs.
    Ohlsson K; Olsson R; Björk P; Balldin G; Borgström A; Lasson A; Kohno T; Thompson RC
    Scand J Gastroenterol; 1989 Aug; 24(6):693-704. PubMed ID: 2814337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of a cholecystokinin receptor antagonist lorglumid on the proteinase-antiproteinase balance in taurocholate acute experimental pancreatitis (AEP) in rats.
    Kosidło S; Rydzewska G; Gabryelewicz A
    Mater Med Pol; 1992; 24(4):223-6. PubMed ID: 1308047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic and pharmacodynamic properties of biapenem, a carbapenem antibiotic, in rat experimental model of severe acute pancreatitis.
    Muto Y; Mikami Y; Sakakibara S; Shimizu A; Niida M; Kataoka H; Ito F; Suzuki K; Kijima K; Maebashi K; Takata T; Hikida M; Takeda K; Unno M
    Pancreas; 2008 Mar; 36(2):125-32. PubMed ID: 18376302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of somatostatin on acute pancreatitis induced in rats by injection of taurocholate and trypsin into a temporarily closed duodenal loop.
    De Rai P; Franciosi C; Confalonieri GM; Biffi R; Andreoni B; Uggeri F; Malesci A
    Int J Pancreatol; 1988 Jul; 3(5):367-73. PubMed ID: 2902146
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pioglitazone attenuates the severity of sodium taurocholate-induced severe acute pancreatitis.
    Xu P; Zhou XJ; Chen LQ; Chen J; Xie Y; Lv LH; Hou XH
    World J Gastroenterol; 2007 Apr; 13(13):1983-8. PubMed ID: 17461502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effective intraperitoneal antiprotease therapy for taurocholate-induced pancreatitis in rats.
    Wilson C; Imrie CW
    Br J Surg; 1990 Nov; 77(11):1252-5. PubMed ID: 1701328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histopathological sequential changes in sodium taurocholate-induced acute pancreatitis.
    Kudari A; Wig JD; Vaiphei K; Kochhar R; Majumdar S; Gupta R; Yadav TD; Doley RP
    JOP; 2007 Sep; 8(5):564-72. PubMed ID: 17873460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Octreotide ameliorates glucose intolerance following acute experimental pancreatitis.
    Avni B; Haddad R; Kashtan H; Kaplan D; Graf E; Siegal A; Skornick Y; Kaplan O
    Dig Dis Sci; 1998 Jan; 43(1):193-202. PubMed ID: 9508525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Protective effect of pancreatic enzyme depletion in the course of acute pancreatitis--experimental study in rats].
    Coelho AM; Kubrusly MS; Bonizzia A; Gonçalez Y; Abdo EE; Machado MC
    Rev Hosp Clin Fac Med Sao Paulo; 1993; 48(3):106-11. PubMed ID: 8248698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined therapy of a cephalosporin, Shiomarin and a new potent protease inhibitor, E3123 in rat taurocholate-induced pancreatitis.
    Hirano T; Manabe T
    Nihon Geka Hokan; 1992 Nov; 61(6):423-32. PubMed ID: 1306980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of nuclear factor-kappaB activation improves the survival of rats with taurocholate pancreatitis.
    Satoh A; Shimosegawa T; Fujita M; Kimura K; Masamune A; Koizumi M; Toyota T
    Gut; 1999 Feb; 44(2):253-8. PubMed ID: 9895386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.